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Abstract
Background: Integrating non-viral vectors based on transposable elements are widely used for genetically engineering
mammalian cells in functional genomics and therapeutic gene transfer. For the Sleeping Beauty (SB) transposase system it
was demonstrated that convergent transcription driven by the SB transposase inverted repeats (IRs) in eukaryotic cells
occurs after somatic integration. This could lead to formation of double-stranded RNAs potentially presenting targets for
the RNA interference (RNAi) machinery and subsequently resulting into silencing of the transgene. Therefore, we aimed at
investigating transgene expression upon transposition under RNA interference knockdown conditions.
Principal Findings: To establish RNAi knockdown cell lines we took advantage of the P19 protein, which is derived from the
tomato bushy stunt virus. P19 binds and inhibits 21 nucleotides long, small-interfering RNAs and was shown to sufficiently
suppress RNAi. We found that transgene expression upon SB mediated transposition was enhanced, resulting into a 3.2-fold
increased amount of colony forming units (CFU) after transposition. In contrast, if the transgene cassette is insulated from
the influence of chromosomal position effects by the chicken-derived cHS4 insulating sequences or when applying the Forg
Prince transposon system, that displays only negligible transcriptional activity, similar numbers of CFUs were obtained.
Conclusion: In summary, we provide evidence for the first time that after somatic integration transposon derived transgene
expression is regulated by the endogenous RNAi machinery. In the future this finding will help to further improve the
molecular design of the SB transposase vector system.
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Introduction
Over the recent years various improved recombinases for
somatic integration into the host genome were developed.
Predominant integration systems currently being explored in
mammalian cells are the transposable elements represented by the
Sleeping Beauty (SB) transposase, the Frog Prince (FP) transposon,
the piggyBac transposable element and the bacteriophage-derived
integrase PhiC31 for targeted integration [1,2,3,4,5,6].All systems
are widely being studied in multiple applications including gene-
therapeutic applications and functional genomics [7,8,9,10].
The SB transposase system represents one of the most
prominent non-viral gene therapy vectors because it can efficiently
and stably integrate therapeutic DNA into mammalian genomes.
SB transposase is a synthetic transposable element derived from
fish [2]. The integration reaction is based on a cut-and-paste
mechanism, which leads to genomic integration of the gene of
interest, flanked by the SB inverted repeats (IRs) into a TA-
dinucleotide within the genomic DNA. Multiple SB-based animal
studies demonstrated efficacy in mice including stable correction of
genetic disorders in clinically relevant animal models
[11,12,13,14].
There is accumulating evidence in invertebrates that DNA
transposition is regulated by the endogenous RNA interference
(RNAi) pathway [15,16,17], a mechanism responsible for
transcriptional [18,19,20] and post-transcriptional gene silencing
[21,22,23]. In these systems endogenously produced 21- to 25-
nucleotide long non-coding micro RNAs (miRNAs) play a major
role in downregulation of the transposase leading to inhibition of
transposition in the respective cell [17,24]. However, only limited
information is available regarding the potential influence of
miRNA pathway on DNA transposons in mammalian cells. A
recent study showed that the LINE-1 retrotransposition is
suppressed by endogenous small interfering RNAs [25]. Hereby,
bidirectional dsRNA transcripts from the transposon represent
targets for the RNAi machinery indicating that the RNAi pathway
controls transposition in mammalian cells.
Herein, we hypothesized that transgene expression upon SB-
mediated somatic integration may be regulated by the endogenous
miRNA pathway. Recent data demonstrated that IRs display
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inward transcriptional activities in eukaryotic cells [26,27] and this
convergent transcription may lead to formation of double-stranded
RNA (dsRNA) templates for the endogenous RNAi machinery
which could lead to epigenetic silencing of transgene expression.
This hypothesis is further supported by recent studies showing that
epigenetic transgene silencing and therefore control of transgene
expression can be mediated by convergent transcription and it is
speculated that the mRNA specific micro RNAs and components
of the RNA interference pathway play a role in this process
[19,28,29].
Our experimental approach was based on generation of RNAi
knockdown cell lines based on the RNAi inhibitor protein P19
derived from the tomato bushy stunt virus [30,31], which inhibits
21 nt long small-interfering RNAs (siRNAs) [32,33,34]. To
ascertain the impact of the RNAi pathway on transgene expression
upon SB-mediated transposition, we quantified successful trans-
position events under selection pressure after transposition of a
transposon containing a resistance gene as a direct indicator for
transgene expression. We found up to 3.2-fold enhanced number
of colony forming units in our RNAi knockdown cells supporting
our hypothesis that RNAi reduces transgene expression in
mammalian cells.
Results
Generation and Characterization of RNA Interference
Knockdown Cells Based on the RNA Interference
Inhibitor Protein P19
There is evidence that SB transposase derived IRs display
convergent transcriptional activities in eukaryotic cells [26,27].
This inward transcription may lead to formation of double-
stranded RNA templates for the endogenous RNAi machinery.
These findings motivated us to investigate whether transgene
expression upon SB transposase-mediated somatic integration in
mammalian cells is influenced by these miRNAs. To address this
question our experimental approach was to generate RNAi
knockdown mammalian cell lines, which can be used for
evaluation of transposon-derived transgene expression levels after
somatic integration.
Our hypothesis that transgene expression upon Sleeping Beauty
mediated transposition is regulated by the RNA interference
pathway is based on the formation of dsRNAs due to IR driven
convergent transcription. In order to confirm the existence of
dsRNAs originated from the transpsoson, we transfected a SB
expressing plasmid (pCMV-SB) together with a plasmid harbour-
ing the transposon (pTnori) and as control the SB transposase
alone (Figure S1 A). Small RNAs were isolated 2 and 6 days post-
infection and treated with RNase A and DNase to destroy of
single-stranded RNAs and DNA, respectively. After the polyad-
enylation process, dsRNAs were reverse-transcribed and the
cDNA was analyzed by PCR. PCR analysis revealed dsRNAs
directed against the SV40 promoter and the neomycin reporter
gene (Figure S1 B), whereas no dsRNA for the SV40 polyA signal
or any larger dsRNAs covering the entire transposon (data not
shown) could be detected. Thus, we were able to show that
dsRNAs are generated from the transposon donor vector after SB
mediated transposition, which have the potential to mediate either
transcriptional or post-transcriptional gene silencing.
To establish RNAi knockdown cell lines we took advantage of
the P19 protein, which is derived from the tomato bushy stunt
virus [30,31]. It binds and inhibits 21 nucleotide (nt) long, small
interfering RNAs (siRNAs) and was shown to sufficiently suppress
RNAi [33,34,35]. To check whether P19 is functional, we
performed reporter assays in the human embryonic kidney cell
line HEK293. In this assay the abrogated effect of an established
small inhibitor RNA (siRNA) against a reporter directly correlates
with P19 activity. We transfected HEK293 cells with a luciferase
expressing plasmid along with either a P19 expressing plasmid
(p19Topo or p19HA) or a mutated and inactive version of P19
(p19mHA). Twenty-four hours later we transfected either a
previously published siRNA against firefly luciferase (GL3) or an
irrelevant siRNA and 48 hours after the first transfection round we
performed luciferase assays [32]. Plasmid constructs used for this
study are shown in Figure S2 A.We found that P19 could restore
the siRNA-mediated downregulation of firefly luciferase expres-
sion to up to 85% (Figure S2 B, bars 4 and 6), whereas the
mutated form of P19 (p19mHA) could not (Figure S2 B).
Furthermore our data revealed, that the HA-tagged P19 molecules
were not as sufficient in blocking activity of siRNAs as an untagged
version of P19 (Figure S2 B; compare bars 6 [tagged] and 4
[untagged]). Nevertheless, P19 was effective in suppressing siRNA-
mediated silencing in HEK293 cells.
In order to analyze the effect of RNAi on SB transposition we
established RNAi knockdown cell lines stably expressing P19. For
this purpose we followed two strategies. In a first approach we
infected HEK293 cells with a retrovirus expressing P19 as an un-
tagged version and a green fluorescent protein (GFP) encoding
cDNA (p19-MIE, Figure 1A). Using an un-tagged version of P19
could be advantageous because the tagged version of the P19
protein may be less biologically active compared to an un-tagged
version (see also Figure S2 B). Upon retrovirus transduction,
single cell clones expressing GFP were isolated by fluorescence-
activated cell sorting and individual cell clones expressing GFP
were amplified without selection. By this method we could
establish 6 cell clones (G3, G4, G5, G6 G14 and G16) of which
4 clones (G3, G4, G5, G16) expressed GFP as analyzed by flow
cytometry (Figures 1B and 1C). Clones G4 and G16 showed
highest levels of GFP expression and RT-PCR analysis of cDNA
generated from the GFP positiv cell lines could demonstrate
expression of the untagged p19 mRNA (Figure 1D). The second
approach was based on stably transfecting the p19 and neomycin
resistance gene encoding plasmid Kp19 into HEK293 cells
(Figure 1A, bottom panel). After plasmid transfection and
subsequent G418 selection (500 mg/ml), 15 single, neomycin
resistant HEK293-based cell clones were isolated and amplified.
To analyze p19 expression, we performed Western Blot analysis
using a peroxidase labeled anti-His antibody and found that cell
clone B6 showed highest expression levels of both monomeric and
dimeric P19 (Figure 1E) in comparison to two other cell clones
(A1 and A2).
To investigate whether all generated cell lines express a
functional P19 protein, we chose the HoxB8 gene as a marker.
The hoxB8 gene encodes a homeobox protein, a transcription
factor that is only active during development. In differentiated cells
HoxB8 is permanently suppressed by the endogenous miRNA
miR-196a [36] (personal communication, Charles H. Lecellier,
Institut de Ge´ne´tique Humaine, Montpellier, France). Thus, if P19
is functional in our generated cell lines, HoxB8 expression should
be upregulated, which can be measured by quantitative Real-
Time PCR. By this approach we could show a 3.5 to 8-fold
upregulation (p-value,0.05) of HoxB8 in the stable cell clones G4
and B6, respectively, clearly indicating that P19 is a sufficient
inhibitor of the RNAi mechanism in this established cell lines
(Figure 1F). However, all other clones showed only slight or no
increase in HoxB8 amount (Figure 1F). Therefore, the following
studies were performed using the RNAi knockdown cell lines B6
and G4.
Transposition and RNA Interference
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Influence of the RNA Interference Pathway on
Transposon-derived Transgene Expression after
Transposition
As a next step we analyzed the influence of the RNAi pathway
on transgene expression upon transposase mediated transposition
in our RNAi knockdown cell lines. As described previously, we
performed colony-forming assays (CFAs) [11], which allow for
selection and quantification of transposition events in eukaryotic
cells. We hypothesized that surviving cell clones expressed as
colony forming units (CFU) after transposition correlate with
transgene expression levels since no or low resistance gene
expression levels result in cell death due to the selection pressure.
Plasmids used for the analysis of SB transposition are shown in
Figure 2A.
Since these CFAs are based on plasmid transfection into
eukaryotic cells, we initially analyzed plasmid transfection
efficiencies because the knockdown of the RNAi pathway
potentially may have influenced the uptake of plasmid DNA.
Therefore, we co-transfected a reporter plasmid expressing renilla
luciferase and determined transfection efficiencies for each
experiment performed in HEK293, G4 and B6 cells. We found
that transfection efficiencies were comparable in the RNAi
knockdown cell line G4 and the parental cell line HEK293
(Figure 2B, left panel). Although transfection efficiencies were
different in the cell line B6 and the parental cell line, the ratios
Figure 1. Generation and characterization of the RNAi knockdown cell lines. (A) DNA sequences used to generate stable p19 expressing
cell lines. Kp19 was used for stable plasmid transfection of HEK293 cells. The plasmid p19-MIE was used to produce a P19 expressing recombinant
retrovirus for stable infection of HEK293 cells. K: Kozak sequence; pCMV: promoter of the cytomegalovirus; p19: p19 expression cassette; pRSV:
promoter of the rous sarcoma virus; RGS-His: 6 histidin residues connected to the P19 protein by an arginin-glycin-serin motive; Neo: neomycin
resistance cassette that mediates G418 resistance; poly A: polyadenylation signal derived from the simian virus; GFP: green fluorescent protein
expression cassette; LTR: long terminal repeats; IRES: internal ribosome entry site. (B) Flow cytometric analysis of cell clones generated by retroviral
transduction. Single cell clones from cell sorting were amplified and analysed by flow cytometry. Cells appearing in quadrant Q2 refer to GFP+cells. X-
axis: GFP amount; Y-Axis: SSC: side scatter, to measure cell viability. (C) Quantitative analysis of GFP positive clones generated by cell sorting shown in
Fig. 1B. (D) Expression of p19 mRNA in the stable cell lines G3, G4, G5 and G16. The generated cDNA was used for PCR amplification with p19 specific
primers and a 519 bp band indicates positive cell clones. As positive control the p19 expression cassette from the plasmid Kp19 (+c) was amplified. +:
sample with RT; 2: sample without RT; 0: untreated HEK293 cells; M: marker. (E) Detection of P19 expression by Western Blot analysis in stable cell
lines, which express the His-tagged version of the P19 protein. Monomeric and dimeric P19 molecules were detected using a peroxidase labeled anti-
His antibody at 19 kDa and 38 kDa indicated by an arrow in the diagram. As positive control, HEK293 cells were transiently transfected with p19
expressing plasmids (left lane, +c) or mock transfected (-c). (F) Functionality of P19. RNA was isolated from HEK293, B6, G3, G4, G5, G16 cells and
reverse transcribed. The cDNA was used for quantification of the HoxB8 mRNA amount by qRT-PCR. An increase in the HoxB8 level indicates a
functional P19 protein because functional P19 inhibits miR169a- mediated downregulation of HoxB8. Normalization was performed by GAPDH
measurement with GAPDH specific primers. The fold increase of the HoxB8 amount in the RNAi knockdown cell lines was determined in a semi-
quantitative manner. *: p-value,0.05.
doi:10.1371/journal.pone.0035389.g001
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between the groups, which received the functional protein (SB)
compared to the mutated version (mSB) were similar (Figure 2B,
right panel). As described below we also considered this in our
transposition analysis.
To analyze the efficiency of SB-mediated transposition, we co-
transfected the RNAi knockdown cell lines G4 and B6 and the
parental HEK293 cell line with the respective transposon donor
vector (pTnori or pTMCS-IP) and either a plasmid encoding wild
type SB (pCMV-SB) or the inactive version of the SB transposase
(pCMV-mSB) at a molar ratio of 1:4 (SB : transposon donor
vector, Figure 2A). For CFAs performed in neomycin resistant B6
cells we utilized the transposon donor vector pTMCS-IP
(Figure 2A) containing a puromycin resistance gene and for the
G4 cell line we transfected the transposon donor plasmid pTnori
(Figure 2A) encoding a neomycin resistance gene. After two
weeks of G418 or puromycin selection the total number of colony-
forming units (CFU) was quantified by counting colonies after
methylene blue staining. All experiments were performed in
triplicates and the average results of three independent exper-
iments are shown.
To evaluate the results of the CFAs, we first analyzed the
transposition rates in the RNAi-deficient cell lines and the parental
Figure 2. Influence of the RNA interference (RNAi) pathway on integration events mediated by Sleeping Beauty (SB) transposase
and Frog Prince (FP) transposase. (A) Shown are all DNA constructs used to analyze the influence of the RNAi pathway on SB mediated
transposition in HEK293 cells and the RNAi knockdown cell lines G4 and B6. The vector pTnori with the neomycin resistance gene was used as a
transposon donor vector in G4 cells and pTMCS-IP was used in B6 cells. pCMV: major immediate early promoter/enhancer; IRES: internal ribosome
entry side of the encephalomyocarditis virus (ECMV); Puro: puromycin-N-acetyl-transferase gene mediates puromycin resistance; bpolyA: bovine
growth hormone A polyA signal; polyA: SV40 polyA signal; Neo: neomycin resistance cassette mediating G418 resistance; SB: SB transposase; mSB:
mutated version of the Sleeping Beauty transposase; IR: inverted repeats recognized by SB. (B) Analysis of transfection efficiencies in HEK293, G4 (left
panel) and B6 cells (right panel) two days post-transfection of the DNA constructs used for SB-mediated transposition. Instead of 100 ng stuffer
plasmid as used for integration assays, 100 ng of the renilla luciferase expressing plasmid pRL-TK were transfected into 6-well plates and relative light
units were determined. For details please refer to the material and methods section. The amount of relative light units correlates with the transfection
efficiency. (C) Total number of colony forming units (CFUs) after SB transposase mediated integration in HEK293 cells and the RNAi knockdown cell
lines G4 (left panel) or B6 (right panel). The fold increase in transposition events compared to the inactive protein is shown in numbers above the
respective bars. All experiments were performed in triplicates and were statistically relevant (p-value,0.05). *: p-value,0.05. (D) The fold increase in
integration events directly comparing the parental cell line HEK293 and the respective RNAi knockdown cell line for the SB transposase and the Frog
Prince (FP) transposase are shown. (E) Shown are all DNA constructs used to analyze the influence of the RNAi pathway on FP mediated transposition
in HEK293 cells and the RNAi knockdown cell lines G4 and B6. The transposon donor vector pFP-IP with the puromycin resistance gene was used in
B6 cells and pFP-neo2 was used in G4 cells. P beta actin: beta actin promoter; FP: Frog Prince transposase; 4a: empty vector without FP transposase;
IR: inverted repeats recognized by FP. (F) Analysis of transfection efficiencies in HEK293, G4 and B6 cells for the FP transposase system two days post-
transfection. The amount of relative light units correlates with the transfection efficiency. (G) Total number of CFUs after Frog Prince mediated
transposition in HEK293 cells and the RNAi knockdown cell lines G4 (left panel) or B6 (right panel). The fold increase in transposition events is
expressed in numbers above the respective bars. The data comparing the active transposase with its inactive version within one cell line are
statistically relevant (p-value,0.05). All experiments were performed in triplicates. * p-value,0.05.
doi:10.1371/journal.pone.0035389.g002
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cell line HEK293, independently. For each cell line and condition
(SB or mSB) the amount of CFUs was quantified and transposition
efficiencies were then expressed as the fold increase of SB-
mediated integration events compared to cells, which received the
inactive mSB. Importantly, this also takes into account variables
like different cell states, cell growth or drug resistance. As displayed
in Figure 2C this ratio of CFUs between functional (SB) and
inactive (mSB) SB transposase was 8.0 and 3.5 in HEK293 cells,
26.1 in G4 cells and 8.9 in B6 cells, respectively. Afterwards, these
data were used to directly compare colony-formation in the RNAi
knockdown and HEK293 cells. In addition, the different
transfection efficiencies were included in the calculation. As
summarized in Figure 2D (dark grey bars) we found that in
contrast to the parental cell line HEK293, SB-mediated integra-
tion showed at average an increase of 3.2-fold in the RNAi
knockdown cell line G4 and an enhancement of 2.5-fold in the B6
cell line (p-value,0.05). Hence, we concluded that the RNAi
pathway may interfere with transposon-derived transgene expres-
sion in mammalian cells and it could be speculated that epigenetic
silencing, a process which as mentioned above can be regulated by
the RNAi pathway, is responsible for modified transgene
expression in P19 expressing cells.
Previous studies suggested that the Frog Prince (FP) transposon
does not display convergent transcription, thus this system may not
be influenced through the RNAi pathway [26]. Therefore, we
speculated that the FP transposon system could be potentially used
as a negative control for expression without impact of the RNAi
pathway. FP is a reconstructed transposon from the Northern
Leopard Frog Rana pipiens displaying high transpositional activity
in vertebrate cells [4]. Similar to SB it works by a cut-and-paste
mechanism leading to somatic integration into TA dinucleotides
[4]. Plasmids used for the analysis of FP transposition in our RNAi
knockdown cell lines are shown in Figure 2E. As for the SB
transposase we first analyzed transfection efficiencies for all cell
lines either receiving the active FP or an empty control vector (4a).
Comparable to the results obtained for SB, the ratios for the
transfection efficiencies were comparable for HEK293 cells and
G4 cells (Figure 2F, left panel) and lower in the cell line B6 if
directly compared to the parental cell line (Figure 2F, right
panel).
In concordance to our studies utilizing the SB transposase
system, we performed CFAs with the FP system in our RNAi
knockdown cells G4 (Figure 2G, left panel) and B6 (Figure 2G,
right panel) and the parental HEK293 cell line. The experimental
setup was identical to the one used for SB and the total number of
colonies for all cell lines are shown in Figure 2G. As displayed in
Figure 2G the ratios of CFUs between functional (FP) transposase
and the empty control vector (4a) were 8.3 and 3,9 in HEK293
cells, 8.2 in G4 cells (left panel) and 3,3 in B6 cells (right panel),
respectively. Therefore, as hypothesized we could not detect a
significant difference in CFU ratios in the RNAi knockdown cell
lines in comparison to HEK293 cells after transfection of the FP
expressing plasmid and the donor plasmids pFP-IP or pFP-neo2 at
a molar ratio of 1:5 (pFV-FP: substrate plasmid) (Figure 2G). The
fold change in CFUs after FP transposition in G4 (similar) and B6
cells (up to 1.3-fold increase; p-value.0.05) in direct comparison
to HEK293 cells is summarized in Figure 2D (bright grey bars).
We concluded that transgene expression upon FP transposase
mediated integration is not influenced by the RNAi machinery.
Notably, the comparative analysis of the two experiments using
Frog Prince and SB, in which we compared transposition ratios in
the parental and the RNAi negative cell lines takes into account
different conditions used, such as different promoters or in the case
of FP using an empty control vector.
The Effect of the RNAi Interence Pathway on Transposon-
deirved Transgene Expression can be Abrogated by
Insulator Sequences
In order to further characterize the observed phenomenon in
our RNAi knockdown cell lines on a molecular level, we
performed CFAs and quantified SB-mediated transposition events
from the substrate plasmid T/neo-HS4, containing two chicken b-
globin insulating sequences (cHS4) [27]. There is evidence that
these insulating sequences significantly reduce chromosomal
position effects caused by enhancers present in the genome and
it was shown that cHS4 sequences reduce epigenetic silencing
based on hyperacetylation of histones H3 and H4 and reduction in
CpG methylation [37,38]. We performed CFAs transfecting T/
neo-HS4 (Figure 3A) either with the functional SB or the inactive
version of SB (mSB) in HEK293 cells and G4 cells using
comparable conditions as in the experiments shown in Figure 2.
After two weeks of G418 selection no significant differences in the
ratio of transposition frequencies for the SB and the mSB group
between HEK293 cells and the RNAi knockdown cell line G4
were observed (Figure 3B), indicating no RNAi-mediated
decrease of transposon-derived transgene expression when using
the cHS4 insulating sequences. This experiment supports the
notion that really the RNAi mediated inhibition of the epigenetic
mechanism, such as methylation of DNA or histones or
deacetylation of DNA, drives downregulation of expression
derived from integrated transposons.
Transposon-derived Transgene Expression Levels are
Higher in RNA Interference Knock-down Cells
In order to confirm our hypothesis that decreased transgene
expression from the integrated transposon is the cause of reduced
colony formation after transposition, we analyzed transgene
expression levels after transposition from the donor vectors pTnori
and pTMCS-IP. Therefore, we measured neomycin and puro-
mycin expression levels by quantitative Real-Time PCR (qRT-
PCR) 10 days (G4 cells) and 21 days (B6 cells) post-transfection
using neomycin or puromycin specific primers. Results were
normalized to expression of 1000 human beta2 microglobulin
RNA molecules. As shown in Figures 4A and 4B expression
levels were higher in both RNAi knockdown cell lines G4
(Figure 4A, neomycin) and B6 (Figure 4B, puromycin) when
directly compared to the parental cell line HEK293. The fold
increase in neomycin and puromycin expression is displayed in
Figures 4C (neomycin) and 4D (puromycin), indicating up to 3-
to 5-fold increased transgene expression levels compared to
HEK293 cells, respectively. These results suggested that higher
transposon derived transgene expression levels can be one reason
for increased CFU obtained from CFA in RNAi knockdown cells.
To rule out if SB activities itself were modified in our RNAi
knockdown cell lines and therefore responsible for differences in
transposition events, we measured SB transposase activities by
quantifying transposase mediated excision efficiencies from
transposon donor plasmids by qRT-PCR. However, no differences
in excision activities were detected (Figure S3).
Discussion
In conclusion, our results indicate that transgene expression
upon SB-mediated transposition in human cells is regulated
through the RNAi pathway. There are several mechanisms
possible for this phenomenon including suppression of mRNA
expression at the gene level by introducing repressive chromatin
modifications or at the mRNA level based on mRNA degradation
or inhibition of translation. With respect to the latter point, one
Transposition and RNA Interference
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explanation could be that formed dsRNAs are exported out of the
nucleus into the cytoplasm [39,40] and that these RNAs may serve
as substrates for Dicer, an endonuclease, which cleaves the long
dsRNAs into 21–23 nt long siRNAs [41,42]. One strand of these
siRNAs, the so-called guide strand can then be incorporated into
the RNA-induced silencing complex (RISC) and direct siRNA
mediated silencing of the transgene after somatic integration
[41,43,44]. Transcriptional silencing can also be mediated by
siRNAs directed against promoter regions or transcriptional start-
sites [45]. In agreement with this latter point, we detected dsRNAs
originating from the SV-40 promoter region (Figure S1 B).
Our experiments using the cHS4 insulating sequences capable
of inhibiting epigenetic silencing revealed no enhanced number of
CFUs in RNAi knockdown cells (Figure 3). This result indicated
that epigenetic silencing, such as methylation of DNA or histones
or deacetylation of DNA, could drive downregulation of expres-
sion derived from integrated transposons. This is further supported
by the data from Garrison and colleagues as they demonstrated
increased transgene expression after Sleeping Beauty mediated
transposition by applying methyltransferase inhibitors [46]. In
conclusion, the results indicate that post-transposition silencing
could be the primary cause of transgene silencing after SB
mediated transposition. However, it remains to be analyzed
whether and to which extent histone or/and DNA methylation
occurs and this is also discussed quite controversial in the literature
[18,47]. One hypothesis is that first histone silencing occurs and
this initiates the methylation of DNA sequences, which subse-
quently leads to heterochromatin formation. Chromosomal
immunoprecipitation assays may solve the question in the case
of the Sleeping Beauty transposition but other mechanisms such as
de-acetylation cannot be excluded by this assay.
Figure 3. Analysis of the effect of insulator sequences on SB mediated transposition in HEK293 cells and the RNAi knockdown cell
line G4. (A) DNA construct used for the study. pCMV: major immediate early promoter/enhancer; polyA: poly adenylation signal of the simian virus
40; SB: Sleeping Beauty (SB) transposase; mSB: non-functional version of the SB transposase; neo: neomycin resistance cassette; HS4: chicken insulator.
(B) The substrate plasmid T/neo-HS4 was transfected into HEK293 or G4 cells along with either the functional Sleeping Beauty transposase (SB) or the
inactive version of SB (mSB). After 2 weeks of G418 selection, cells were stained and blue colonies were counted. The ratios of transposition events (SB
to mSB) in G4 cells and HEK293 cells are displayed.
doi:10.1371/journal.pone.0035389.g003
Figure 4. Quantification of transposon-derived transgene expression after Sleeping Beauty (SB) mediated transposition in HEK293
cells and the RNAi knockdown cell line G4 and B6. Transposon donor plasmids (pTnori for G4 cells and pTMCS-IP for B6 cells) and active or
inactive SB transposase encoding plasmids (pCMC-SB and pCMV-mSB) were co-transfected into HEK293 cells and RNAi knockdown cell lines G4 and
B6. Ten days (G4 cells) and 21 days (B6 cells) post-transfection, RNA was isolated from non-selected cells and reverse transcribed. The cDNA was then
subjected to quantitative Real-Time PCR using neomycin or puromycin specific primers. Results were normalized to expression of 1000 human beta2
microglobulin RNA molecules. (A) Normalized neomycin (neo) expression in G4 cells compared to HEK293 cells. (B) Normalized puromycin (puro)
expression in B6 and HEK293 cells. (C) The fold increase in neomycin expression is shown. Transgene expression in HEK293 cells was set to 1. (D) The
fold increase in puromycin expression levels is is displayed. All data are statistically relevant (p-value,0.05).
doi:10.1371/journal.pone.0035389.g004
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Notably, we not only detected dsRNAs against the SV-40
promoter region but also against the neomycin resistance gene and
therefore, one could expect that the transgene itself is affected
directly by post-transcriptional silencing mechanisms. Correspond-
ing to knowledge about silencing mechanisms we speculate that at
early time points post-transcriptional silencing based RNAi and
dsRNAs plays an important role but persistent transgene
downregulation may be mediated by epigenetic mechanisms
resulting in heterochromatin formation.
Our hypothesis that IR driven dsRNA formation is responsible
for increased numbers of CFUs in the RNAi knockdown cell line is
also supported by other experiments performed in this study.
Analysing the Frog Prince transposon system, for which no
transcriptional activities derived from the IRs were demonstrated
in the past [26], colony forming numbers after resistance gene
selection were similar in the RNAi knockdown cell line and the
parental cell line HEK293 (Figure 2G). Moreover quantification
of transposon-derived reporter gene mRNA levels in G4 and B6
cells indicated significantly increased transgene expression levels in
comparison to HEK293 cells (Figure 4). Thus, the obtained
results confirm the assumption that transgene expression and not
for instance increased transposase activities or levels contribute to
the enhanced colony forming units detected in RNAi knockdown
cell lines.
Interestingly, although the inhibition of the RNAi pathway
seems to be influenced stronger in B6 cells compared to the G4
cells as indicated by the quantification of the HoxB8 expression
levels (Figure 1F), we could not detect the same trend in the CFA
analyzing transposition events. However, it is important to point
out that different plasmid constructs were used to quantify
integration events in the G4 and B6 cells. All substrate plasmids
used for CFAs in B6 cells containing the puromycin expression
cassette also harbour an intron as well as an IRES sequence. Since
the transcriptional activity of the transposon IRs is relatively low
[26], these components may function as insulators or they may
interfere with the convergent transcription levels from the IRs after
somatic integration. Additionally, transcriptional silencing may
also explain the divergence we detected in between the assays in
the G4 and the B6 cells. Different promoters and vector
constitutions used in these assays may be affected in different
dimensions by silencing processes. Nevertheless, the use of two
independent plasmids may suggest that RNAi regulated mecha-
nisms are conserved and independent of the transgene itself and
the usage of longer and more complex transposons may reduce
silencing processes.
In the present study we analyzed the commonly used two-
component vector system for SB-mediated integration and
observed an up to 3.2-fold increase CFUs in the RNAi knockdown
cell line. However, effects may be increased when using the wild
type SB transposase IRs with a 160 bp region between the left IR
and the transposase translational start site with unknown function.
This region was recently shown to enhance transcriptional
activities from the left IR [27], which in turn may lead to an
increased amount of dsRNA and therefore, potentially a more
pronounced silencing effect.
In conclusion, our data indicate that the RNAi pathway
regulates transposon-derived transgene expression potentially
mediated by epigenetic silencing. In the future the established
RNAi knockdown cell lines G4 and B6 can also be explored to
study not only non-viral vectors and their regulation by the RNAi
machinery, but also the influence of RNAi on viral vectors or
viruses in general can be investigated. For instance herpesviruses
and adenoviruses, which were shown to express siRNAs could be
interesting candidates to address these questions [48,49,50,51].
Last but not least our experimental approach based on expression
of P19 may also be applied to study the interference of the RNAi
pathway with viral or non-viral systems in vivo in a tissue specific
manner. P19 could be expressed from a viral vector under the
control of a tissue specific promoter, which may lead to tissue
specific block of 21 nt long small interfering RNAs and therefore
also inhibition of RNAi pathway.
Materials and Methods
Plasmid Construction
The plasmids pCMV-SB, pCMV-mSB, and pTnori were
described elsewhere [11,13]. The plasmids for Frog Prince
transposition, pFV-FP, pFP-4a, pFP-neo, pFP-MCS and the T/
neo-HS4 were kindly provided by Csaba Miskey and Zoltan Ivics
(Max-Delbru¨ck Center, Berlin, Germany)[4]. For construction of
the plasmid pTMCS-IP, pIRESpuro2 (Clontech) was digested
with XhoI, NruI and NheI and the resulting 2678 bp fragment
containing the puromycin resistance cassette was introduced into
the BglII restriction site of pT-MCS [13] by blunt end cloning.
Moreover, the same 2678 bp fragment was inserted into the EcoRI
site of pFP-MCS resulting into the plasmid pFP-IP. For the
plasmid pTMCS-RL, the plasmid pT-MCS was digested with
XbaI and KpnI, the ends were refilled using T4 DNA polymerase
and subsequently the ends were religated again. The stuffer
plasmid pBSP/PDNot was described elsewhere [8,12,52]. Trans-
fection efficiencies in RNAi knockdown cell lines were determined
using the plasmid pRL-TK expressing renilla luciferase (Promega).
The plasmids used for the stable transfection of a P19 expression
cassette were constructed with the gateway technology (Invitro-
gen). First, the p19 expression cassette was PCR amplified (without
stop codon) with the primer Gp19forwK (59AAAAAG-
CAGGCTCCGCCATGGAACGAGCTATACAAGGAA-39)
and the reverse primer Gp19rev
(59AGAAAGCTGGGTCGCTTTCTTTTTCGAAGGTTT-
GAG 39) harboring a Kozak sequence for eukaryotic expression.
To create homologous regions for recombination, attB specific
primers were used for the nested PCR (One-for-all-forward: 59-
GGGGACAAGTTTGTACAAAAAAGCAGGCT-39 and One-
for-all-reverse: 59-GGGGACCACTTTGTACAA-
GAAAGCTGGGTC-39). Using BP clonase the PCR fragment
was introduced into the attP sites of pDonr207 and in the second
LR clonase reaction p19 was cloned into the destination vector
pCR3.1 N-His. All Gateway compatible vectors were kindly
provided by Armin Baiker (Max von Pettenkofer-Institute,
Department of Virology, Ludwig-Maximilians-University Munich,
Munich, Germany) [53,54]. These cloning steps resulted into the
plasmid Kp19, which was used to generate a stable p19 expressing
cell line under G418 selection pressure (500 mg/ml) using Super-
fect transfection reagent (Qiagen). The p19 encoding retroviral
vector p19-MIE, for generation of the stable cell line G4 by
retroviral transduction, was produced by triple transfection of
plasmids providing all necessary factors for retrovirus production,
the gag-pol proteins as well as the VSV glycoprotein (all plasmids
were kindly provided by Charles Lecellier (Institut de Ge´ne´tique
Humaine, Montpellier, France) and Olivier Voinnet (Institut de
Biologie Mole´culaire des Plantes, Strasbourg, France).
Plasmids for quantitative Real-Time PCR were constructed as
follows. HoxB8 and GAPDH were amplified from human
genomic DNA from HEK293 cells with the following primers:
HoxB8forw_PD (59-TGGAGCTGGAGAAGGAGTTC-39), Hox-
B8rev_PD (59-CTCCTCCTGCTCGCATTT-39), hGAPDHforw
(59-TGCCTCCTGCACCACCAACT-39) and hGAPDHrev (59-
CGCCTGCTTCACCACCTTC-39) and either cloned into the
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EcoRI site of the the pBSP/PDNot vector or into the commercial
available pCR-Blunt II-TOPO (Invitrogen) vector, respectively,
following the manufacturer instructions. Plasmid phB2m was a
kind gift from Wenli Zhang (Max von Pettenkofer-Institute,
Department of Virology, Ludwig-Maximilians-University Munich,
Munich, Germany).
Specific Analysis of dsRNAs Generated from the
Transposon Donor Vector after SB Mediated
Transposition
In order to confirm our fundamental hypothesis that dsRNAs
are generated after SB mediated transposition we transfected 6-
well plates of HEK293 cells at a confluency of 50% with 200 ng of
the SB expressing plasmid pCMV-SB and 1000 ng of the
transposon donor vector pTnori using FuGene 6 (Roche) following
the manufacturer instruction. As a control HEK293 cells were
used, which were only transfected with the SB expressing plasmid
DNA. Either 2 or 6 days (control cells only 6 days) post-
transfection small RNAs were isolated using the miRNeasy kit
(Qiagen) also following the manufacturer instructions. To get rid
of unwanted ssRNAs but protect dsRNAs, half of the eluted RNA
was treated with 200 mg/ml RNase A and maintaining a 300 mM
NaCl (DEPC-treated) concentration at 37uC. After 1 hour the
mixture was purified using again the miRNeasy kit. Afterwards the
remaining DNA was digested using DNaseA (Sigma-Aldrich) for
15 min at 37uC and either purified with the miRNeasy kit or using
the provided stop solution to stop the reaction. Colomn purified
RNAs were subjected to a polyadenylation reaction using the
PolyA tailing kit (Ambion) and reverse transcribed by the first strand
cDNA synthesis kit (NEB) with a polydTAdaptor primer(59-
GCGAGCACAGAATTAATACGACTCACTA-
TAGG(T)12VN*-39) [55]. RNAs treated with the stop solution
were immediately used for reverse transcription but using the
random primers provided by the NEB kit. As a control for possible
DNA contamination one sample was not treated with the reverse
transcriptase. The generated cDNA was then inserted into a PCR
reaction using Taq polymerase with either the neomycin specific
forward primer N1 (59-CACCAGGGCAAGGGTCTG-39) and
the reverse primer N2 (59-GCTCGTAGAAGGGGAGGTTG-39)
or the SV40 promoter specific primer SV40f (59-GTTTAAACG-
CATCTCAATTAGTCAGC-39) and SV40r (59-GTTAAT-
TAAAAGCTTTTTGCAAAAGCC-3).
Generation and Characterization of A Stable p19
Expressing Cell Line by Retrovirus Transduction and
Plasmid Transfection
For the production of the retrovirus harboring the p19 cDNA,
the plasmids p19-MIE, the gag-pol expressing plasmid and the
VSV-glycoprotein expressing plasmid were triple-transfected into
HEK293T cells using calcium phosphate transfection following
the protocol from Promega (ProFection @ mammalian cells,
Promega). Two days post transfection cells were harvested and
filtered through a 0,45 mm filter (Millipore) to remove the
remaining cellular material. The viral lysate was then supple-
mented with the same volume of Polybrene (Invitrogen), which
facilitates cellular entry of the virus. Subsequently a 95% confluent
10 cm dish of 293T cells was transduced with the prepared
retroviral lysate. Two days post infection, cells were sorted by
fluorescent activated cell sorting (FACS) and single cell clones
exhibiting GFP expression were sorted in a 96-well plate. These
cell clones were amplified without selection. To check cells for
GFP expression, several amplified cell clones were tested by flow
cytometry using FACS-DIVA. In brief, stable GFP expressing cells
as well as untreated HEK293 cells were harvested, washed once
with PBS and centrifuged 3 min at 500 g. The cell pellet was then
resuspended in PBS containing 0.1% FBS and supplied to the flow
cytometer. Analysis was performed using FACS Diva software and
the percentage of GFP positive cells within one population was
calculated.
The second approach was based on stably transfecting the p19
and neomycin resistance gene encoding plasmid Kp19 into HEK293
cells. HEK293 cells were cultured in DMEM supplemented with
10% FBS and 1% penecillin/streptomycin. Stable transfection of
HEK293 cells with plasmid Kp19 at 70% confluency was
performed using Superfect (Qiagen) according to the manufac-
turer instructions. Two days post transfection cells were seeded in
10 cm dishes at two concentrations (16105 and 16104 cells/dish)
and 500 mg/ml G418 was added. After 14 days of selection, single
cell clones were picked and amplified under G418 selection
pressure.
Western Blot Analysis to Investigate P19 Protein
Expression
For Western Blot analysis a 6 cm tissue culture dish of the cell
lines stably expressing a His-tagged version of P19, HEK293
control cells and transfected HEK293 cells with Kp19 were
collected, washed once with PBS, treated with 300 ml NP-40 lysis
buffer (150 mM NaCl, 1% NP-40, 50 mM Tris (pH 8.0)) and
incubated for 30 min on ice. Protein lysates were separated on a
12% SDS-polyacrylamid gel and transferred to a PVDF mem-
brane (Millipore). Detection of P19 was carried out by a
peroxidase labeled anti-His antibody (Invitrogen) and ECL
reaction (Amersham).
P19 Specific Reverse Transcription PCR to Analyse
Expression from Retrovirus Transduced Cells
The RNA of 3.26106 cells was isolated using the RNeasy kit
(Qiagen) following the manufacturer instructions. After determin-
ing the RNA amount by measuring the optical density, 1 mg RNA
was used for reverse transcription using polydT primer supplied in
the First strand DNA synthesis kit (NEB). As a control, a reaction
without the reverse transcriptase enzyme was performed to
exclude non-integrated plasmids. The generated cDNA was then
subjected to a PCR reaction with p19 specific primers.
Quantitative Real-Time PCR for Quantification of HoxB8,
Neomycin and Puromycin Expression Levels, and Analysis
of SB Transposition Efficiency
A quantitative Real-Time PCR (qRT-PCR) was performed
using 4 ml of cDNA or 50 ng of genomic DNA, 0.5 millimolar
specific primer (see plasmid construction section) and the Light-
Cycler FastStart DNA MasterPLUS SYBR Green I (for HoxB8)
(Roche) or with the FastStart Universal SYBR Green Master (Rox,
Roche). The PCR reaction was run in the Light cycler 2.0 (Roche),
or the TaqMan (Applied Biosystems), respectively. For semi-
quantitative analysis, the vectors pHB2m, pFP-neo (neo qunati-
fication), pIRESpuro (puro quantification) and pTMCS-RL (for
transposition efficiency) were diluted and several 10-fold dilutions
were used to create a standard curve. Quantification of neomycin,
puromycin and SB transposition events were perfomed in a
quantitative manner. Transgene expression levels for neomycin
and puromycin were normalized to 1000 expressed hB2m
molecules. For the neomycin PCR we used the forward primer
N1 (59-CACCAGGGCAAGGGTCTG-39) and the reverse primer
N2 (59-GCTCGTAGAAGGGGAGGTTG-39) resulting in a PCR
product of 110 bp and to analyze puromycin expression levels we
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added primer P3 (59-CTCGTCCTGCAGTTCATTCA-39) and
P4 (59-AGACAATCGGCTGCTCTGAT-39) to the PCR reaction
amplifying a DNA fragment of 118 bp in length. For SB
transposition efficiencies we measured the excision events from
the transposon donor plasmid, which directly correlated with the
amount of amplified fragments using the primer pair puc1 (59-
TACGCCAGCTGGCGAAAG-39) and puc2 (59?AGCTCACT-
CATTGGCAC-39) [56]. For primer sequences used for quanti-
fication of HoxB8 expression please refer to the plasmid
construction section.
Colony Forming Assays (CFAs) for Quantification of
Integration Events
For each colony forming assay (CFA) HEK293 cells and the
RNAi knockdown cell lines B6 and G4 were seeded in 6-well
plates. At 60% confluency cells were transfected with a total of
1 mg plasmid DNA and 10 ml transfection reagent (FuGene6,
Roche). Experiments were performed in triplicates. Two days
post-transfection cells of each 6-well were diluted (1:30) into three
10 cm dishes. Selection with either 500 mg/ml G418 or 600 ng/
ml puromycin was started 72 hours post-transfection and
maintained for 2 weeks. The generated colonies were stained
with methylene blue and counted.
The analysis of SB mediated transposition was performed by co-
transfecting 50 ng pCMV-SB or 50 ng pCMV-mSB, 650 ng
pBSP/PdeltaNot (stuffer DNA) and either 300 ng pTMCS-IP if
B6 cells and puromycin selection were used or 300 ng pTnori or
T/neo-HS4 if G4 cells and G418 selection were used. Frog Prince
mediated transposition events were measured by transfection of
100 ng pFV-FP or 100 ng pFV-4a, 275 ng pBSP/PdeltaNot and
either 625 ng pFP-IP in B6 cells or 625 ng pFPneo2 in G4 cells.
To evaluate transposition events, the ratio of colony-forming
units between groups that received the functional transposase
and groups that received a non-functional protein was
determined. The fold increase in transposition events could be
then identified by directly comparing this ratio in HEK293 cells
and the RNAi knockdown cell lines.
For normalization of the results obtained after performing
CFAs, transfection efficiencies were determined in the context of
the CFA procedure by transfection of 100 ng pRL-TK plasmid
instead of 100 ng of the stuffer plasmid pBSP/PDNot. Two
days post-transfection one sixth of the cell suspension was used
to perform luciferase assays using the dual luciferase reporter
assay (Promega). In order to include transfection efficienies in
our calculation, we normalized the data received from the CFA
to the results of the transfection efficiencies.
Statistical Analysis
Statistical comparison was made by two-tailed Student T-test,
and a value of p,0.05 was considered relevant compared with the
respective control group.
Supporting Information
Figure S1 Detection of dsRNA derived from the trans-
poson after SB mediated transposition. (A) Shown are the
two constructs used to analyse the existence of dsRNAs upon SB
mediated transposition. pCMV: major immediate early promoter/
enhancer; polyA: SV40 polyA signal; Neo: neomycin resistance
cassette mediating G418 resistance; SB: SB transposase; IR:
inverted repeats recognized by SB. (B) DsRNAs from the SB
donor vector appear after SB mediated transposition. Two and six
days after transfection of the SB encoding plasmid and the
transposon encoding plasmid into HEK293 cells, cells were
harvested and small RNAs were isolated. As control, cells, which
were only transfected with the SB expressing plasmid were used.
After Rnase A and DNase treatment, the RNA was reverse
transcribed and subjected to PCR using primers specific for the
SV40 promoter and the neomycin promoter (neo). DNA
contamination was excluded by treating one sample without
reverse transcriptase. M: Marker; d2: sample taken at day 2; d6
sample taken at day 6; c: control sample with only stuffer DNA
transfected taken at day 6; -RT: sample taken at day 6 not
supplemented with reverse transcriptase.
(TIF)
Figure S2 Functionality of P19 in mammalian HEK293
cells. (A) Plasmids used to analyze the functionality of P19 in
mammalian HEK293 cells. pSV40: promoter of the simian virus-
40; p19: p19 expression cassette; p19m: inactive P19 containing an
Arg72 to Glycin exchange; polyA: polyadenylation signal of the
simian virus-40, HA: hemaglutinin-tag. (B) Luficerase assay to
check the functionality of P19. Each sample analyzed contains the
pGL3-Control plasmid (Promega). In addition, for samples
displayed in black bars, either a non-specific stuffer plamsid, a
functional p19 (p19Topo or p19HA) or the mutated version of p19
(p19mHA) was transfected together with a non-specific siRNA. In
the samples referring to the grey bars, however, the GL3 specific
siRNA was transfected together with the pGL3 alone or with one
of the plasmids displayed in (A). RLU: relative light units; GL3:
luciferase specific siRNA; *:p-value.0.5.
(TIF)
Figure S3 Sleeping Beauty (SB) transposase excision
activities are similar in normal and RNA interference
knockdown cell lines. To measure SB transposase activities in
HEK293 cells and the RNAi knockdown cell lines G4 and B6, we
determined transposase mediated excision efficiencies from
transposon donor plasmids by quantitative Real-Time PCR
(qRT-PCR) using the previously published primer pair puc1 and
puc2 [56]. For generation of a standard curve the plasmid
pTMCS-RL was used. Quantification was normalized to 1000
RNA molecules of human beta-2 microglobulin. (A) Quantifica-
tion of SB transposase excision activities from the donor vector
pTnori in HEK293 and G4 cells. The set-up of the qRT-PCR and
the primer binding sites are schematically shown in the left panel.
For the assay, the transposon donor vector pTnori was either co-
transfected with the active SB transposase encoding plasmid
(pCMV-SB) or the inactive transposase encoding plasmid (pCMV-
mSB) into HEK293 and G4 cells. Two days post transfection
whole genomic DNA was isolated and 50 ng genomic DNA was
subjected to qRT-PCR, where excised and religated plasmids
(referring to transposed plasmids, also demonstrated in the left
panel) were quantified (right panel). (B) Excision activities from the
donor vector pTMCS-IP in HEK293 and B6 cells. The
experimental setup (left panel) was identical to the one described
for the excision assay based on the transposon donor vector
pTnori. The right panel shows measured excision activities.
(TIF)
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